Search research articles
Contact Us
Filters
Showing results (21-30 of 50) with videos related to
Page
of 5
Sort By:
Annals of Hematology
|
September 20, 2022
Towards personalized medicine with iPS cell technology: a case report of advanced systemic mastocytosis with associated eosinophilia
Salim Atakhanov, Deborah Christen, Benjamin Rolles, et al.
International Journal of Molecular Sciences
|
December 23, 2023
Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms
Max Bermes, Maria Jimena Rodriguez, Marcelo Augusto Szymanski de Toledo, et al.
Haematologica
|
December 1, 2022
Targeting cytokine-induced leukemic stem cell persistence in chronic myeloid leukemia by IKK2-inhibition
Marlena Bütow, Fabio J Testaquadra, Julian Baumeister, et al.
Leukemia
|
June 21, 2024
Asciminib antagonizes transplantable BCR::ABL1-positive lymphoid blast crisis in vivo by targeting malignant stem cells
Nicolas Chatain, Julian Baumeister, Marcelo A Szymanski de Toledo, et al.
Tropical Medicine and Infectious Disease
|
December 22, 2022
Evaluation of Chiral Organosulfur Compounds on Their Activity against the Malaria Parasite <i>Plasmodium falciparum</i>
Che Julius Ngwa, Rabea Stratmann, Jean Pierre Musabyimana, et al.
Annals of Hematology
|
October 21, 2022
Clonogenic assays improve determination of variant allele frequency of driver mutations in myeloproliferative neoplasms
Milena Kalmer, Kristina Pannen, Rebecca Lemanzyk, et al.
Journal of Hematology & Oncology
|
April 4, 2019
Differential roles of STAT1 and STAT2 in the sensitivity of JAK2V617F- vs. BCR-ABL-positive cells to interferon alpha
Claudia Schubert, Manuel Allhoff, Stefan Tillmann, et al.
Stem Cell Research
|
March 13, 2022
CRISPR/Cas9-engineered human ES cells harboring heterozygous and homozygous c-KIT knockout
Marcelo A S de Toledo, Xuhuang Fu, Frederick Kluge, et al.
Frontiers in Oncology
|
November 9, 2023
The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling
Kathrin Olschok, Bianca Altenburg, Marcelo A S de Toledo, et al.
Plos One
|
April 21, 2015
Dissecting Genomic Aberrations in Myeloproliferative Neoplasms by Multiplex-PCR and Next Generation Sequencing
Martin M J Kirschner, Mirle Schemionek, Claudia Schubert, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 50) with videos related to
Sort By:
Page
of 5
Annals of Hematology
|
September 20, 2022
Towards personalized medicine with iPS cell technology: a case report of advanced systemic mastocytosis with associated eosinophilia
Salim Atakhanov, Deborah Christen, Benjamin Rolles, et al.
International Journal of Molecular Sciences
|
December 23, 2023
Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms
Max Bermes, Maria Jimena Rodriguez, Marcelo Augusto Szymanski de Toledo, et al.
Haematologica
|
December 1, 2022
Targeting cytokine-induced leukemic stem cell persistence in chronic myeloid leukemia by IKK2-inhibition
Marlena Bütow, Fabio J Testaquadra, Julian Baumeister, et al.
Leukemia
|
June 21, 2024
Asciminib antagonizes transplantable BCR::ABL1-positive lymphoid blast crisis in vivo by targeting malignant stem cells
Nicolas Chatain, Julian Baumeister, Marcelo A Szymanski de Toledo, et al.
Tropical Medicine and Infectious Disease
|
December 22, 2022
Evaluation of Chiral Organosulfur Compounds on Their Activity against the Malaria Parasite <i>Plasmodium falciparum</i>
Che Julius Ngwa, Rabea Stratmann, Jean Pierre Musabyimana, et al.
Annals of Hematology
|
October 21, 2022
Clonogenic assays improve determination of variant allele frequency of driver mutations in myeloproliferative neoplasms
Milena Kalmer, Kristina Pannen, Rebecca Lemanzyk, et al.
Journal of Hematology & Oncology
|
April 4, 2019
Differential roles of STAT1 and STAT2 in the sensitivity of JAK2V617F- vs. BCR-ABL-positive cells to interferon alpha
Claudia Schubert, Manuel Allhoff, Stefan Tillmann, et al.
Stem Cell Research
|
March 13, 2022
CRISPR/Cas9-engineered human ES cells harboring heterozygous and homozygous c-KIT knockout
Marcelo A S de Toledo, Xuhuang Fu, Frederick Kluge, et al.
Frontiers in Oncology
|
November 9, 2023
The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling
Kathrin Olschok, Bianca Altenburg, Marcelo A S de Toledo, et al.
Plos One
|
April 21, 2015
Dissecting Genomic Aberrations in Myeloproliferative Neoplasms by Multiplex-PCR and Next Generation Sequencing
Martin M J Kirschner, Mirle Schemionek, Claudia Schubert, et al.
Page
of 5